Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 199–199 | Cite as

Paclitaxel/pertuzumab/trastuzumab

Diarrhoea and fall in left ventricular ejection fraction: 2 case reports
Case report
  • 9 Downloads

Reference

  1. Gupta NK, et al. Effect of a combination of pertuzumab, trastuzumab, and weekly paclitaxel on pCR rates and side-effect profile as a neoadjuvant treatment regimen for HER2-positive breast cancer. Journal of Clinical Oncology 36 (Suppl.): e12652, No. 15, 20 May 2018. Available from: URL: http://doi.org/10.1200/JCO.2018.36.15_suppl.e12652 [abstract] - USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations